共 12 条
[1]
Lancet JE(2018)CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia J Clin Oncol Off J Am Soc Clin Oncol. 36 2684-2692
[2]
Uy GL(2019)Transparency in practice: Evidence from “verification analyses” issued by the Polish Agency for Health Technology Assessment in 2012–2015 Health Econ Policy Law. 14 182-204
[3]
Cortes JE(undefined)undefined undefined undefined undefined-undefined
[4]
Newell LF(undefined)undefined undefined undefined undefined-undefined
[5]
Lin TL(undefined)undefined undefined undefined undefined-undefined
[6]
Ritchie EK(undefined)undefined undefined undefined undefined-undefined
[7]
Ozierański P(undefined)undefined undefined undefined undefined-undefined
[8]
Löblová O(undefined)undefined undefined undefined undefined-undefined
[9]
Nicholls N(undefined)undefined undefined undefined undefined-undefined
[10]
Csanádi M(undefined)undefined undefined undefined undefined-undefined